Top

Published in:

01-03-2013 | Original Article

Spatial patterns of the tau pathology in progressive supranuclear palsy

Authors: Richard A. Armstrong, Nigel J. Cairns

Published in: Neurological Sciences | Issue 3/2013

Abstract

Progressive supranuclear palsy (PSP) is characterized neuropathologically by neuronal loss, gliosis, and the presence of tau-immunoreactive neuronal and glial cell inclusions affecting subcortical and some cortical regions. The objectives of this study were to determine (1) the spatial patterns of the tau-immunoreactive pathology, viz., neurofibrillary tangles (NFT), oligodendroglial inclusions (GI), tufted astrocytes (TA), and Alzheimer’s disease-type neuritic plaques (NP) in PSP and (2) to investigate the spatial correlations between the histological features. Post-mortem material of cortical and subcortical regions of eight PSP cases was studied. Spatial pattern analysis was applied to the NFT, GI, TA, NP, abnormally enlarged neurons (EN), surviving neurons, and glial cells. NFT, GI, and TA were distributed either at random or in regularly distributed clusters. The EN and NP were mainly randomly distributed. Clustering of NFT and EN was more frequent in the cortex and subcortical regions, respectively. Variations in NFT density were not spatially correlated with the densities of either GI or TA, but were positively correlated with the densities of EN and surviving neurons in some regions. (1) NFT were the most widespread tau-immunoreactive pathology in PSP being distributed randomly in subcortical regions and in regular clusters in cortical regions, (2) GI and TA were more localized and exhibited a regular pattern of clustering in subcortical regions, and (3) neuronal and glial cell pathologies were not spatially correlated.

Steele JC, Richardson JC, Olszewski T (1964) Progressive supranuclear palsy. Arch Neurol 10:333–359PubMedCrossRef

Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354:1771–1775PubMedCrossRef

Nath U, Ben-Shlomo Y, Thomson RG et al (2001) The prevalence of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) in the UK. Brain 124:1438–1449PubMedCrossRef

Papapetropoulos S, Gonzalez J, Mash DC (2005) Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. Eur Neurol 54:1–9PubMedCrossRef

Lantos PL (1994) The neuropathology of progressive supranuclear palsy. J Neural Transm (Suppl.) 42:137–152CrossRef

Gomez-Haro C, Espert-Torbajada R, Gadea-Domenech M, Navarro-Humanes JF (1999) Progressive supranuclear palsy: neurological, neuropathological and neuropsychological aspects. Rev de Neurol 9:936–956

Armstrong RA, Lantos PL, Cairns NJ (2009) Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 28:46–53PubMed

Armstrong RA, Cairns NJ (2009) Laminar distribution of the pathological changes in frontal and temporal lobes in eight patients with progressive supranuclear palsy. Clin Neuropathol 28:350–357PubMed

Cordata NJ, Duggins AJ, Halliday GM, Morris JGL, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259–1266CrossRef

10.

Daniel SE, Bebruin VMS, Lees AJ (1995) The clinical and pathological spectrum of Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy)—a reappraisal. Brain 118:759–770PubMedCrossRef

11.

Tellez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele–Richardson–Olszewski syndrome. Arch Neurol 29:324–327PubMedCrossRef

12.

Montpetit V, Clapin DF, Guberman M (1985) Substructure of 20 nm filaments of progressive supranuclear palsy. Acta Neuropathol 68:311–318PubMedCrossRef

13.

Dickson DW (1999) Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:6–15CrossRef

14.

Dickson DW (2003) Neurodegeneration: the molecular pathology of dementia and movement disorders. International Society for Neuropathology (ISN) Press, Basel

15.

Cairns NJ, Lee VM-Y, Trojanowski JQ (2004) The cytoskeleton in neurodegenerative disease. J Pathol 204:438–449PubMedCrossRef

16.

Mackenzie IRA, Hudson LP (1995) Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol 90:615–619PubMedCrossRef

17.

Yamada T, McGeer PL, McGeer EG (1992) Appearance of paired nucleated tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135:99–102PubMedCrossRef

18.

Ikeda K, Akiyama H, Kondo H et al (1995) Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles. Acta Neuropathol 90:620–625PubMedCrossRef

19.

Komori T (1999) Tau positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. Brain Pathol 9:663–679PubMedCrossRef

20.

Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RKB (1999) Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:1–5CrossRef

21.

Arima K, Nakamura M, Sunohara N et al (1999) Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy. Acta Neuropathol 97:565–576PubMedCrossRef

22.

Armstrong RA, Cairns NJ, Lantos PL (2001) What does the study of spatial patterns tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 21:1–12PubMedCrossRef

23.

De Lacoste M, White CL III (1993) The role of cortical connectivity in Alzheimer’s disease pathogenesis: a review and model system. Neurobiol Aging 14:1–16PubMedCrossRef

24.

Hiorns RW, Neal JW, Pearson RCA, Powell TPS (1991) Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc R Soc Lond 246:1–9CrossRef

25.

Armstrong RA, Lantos PL, Cairns NJ (2007) Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy. Parkinsonism Relat Disord 13:50–54PubMedCrossRef

26.

Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 47:1–9PubMedCrossRef

27.

Litvan I, Hauw JJ, Bartko JJ et al (1996) Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropath Exp Neurol 55:97–105PubMedCrossRef

28.

Hauw JJ, Daniel SE, Dickson D et al (1994) Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (PSP). Neurology 44:2015–2019PubMedCrossRef

29.

Williams DR, Holton JL, Strand K, de Silva R, Lees AJ, Revesz T (2007) Differences in tau load are associated with different clinical phenotypes in progressive supranuclear palsy. Neuropathol Appl Neurobiol 33:256–257

30.

Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33:403–408PubMedCrossRef

31.

Mattila P, Togo T, Dickson DW (2002) The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and in advanced Alzheimer’s disease. Neurosci Lett 320:81–85PubMedCrossRef

32.

Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, Ojika K (2003) Distribution of astrocytic plaques in corticobasal degeneration brain and comparison with tuft shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol 106:143–149PubMedCrossRef

33.

Aoki K, Uchihara T, Nakamura A, Komori T, Arai N, Mizutani T (2003) Expression of apolipoprotein E in ballooned neurons: comparative immunohistochemical study in neurodegenerative disorders and infarctions. Acta Neuropathol 106:436–440PubMedCrossRef

34.

Fujino Y, Delucia MW, Davies P, Dickson DW (2004) Ballooned neurons in the limbic lobe are associated with Alzheimer-type pathology and lack diagnostic specificity. Neuropathol Appl Neurobiol 30:676–682PubMedCrossRef

35.

Minamu M, Mizutani T, Kawanishi R, Suzuki Y, Mori H (2003) Neuronal expression of alpha B crystalline in cerebral infarction. Acta Neuropathol 105:549–554

36.

Armstrong RA (1993) The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders with special reference to plaque formation in Alzheimer’s disease. Neurodegeneration 2:73–80

37.

Armstrong RA (2006) Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc 221:153–158PubMedCrossRef

38.

Armstrong RA (2003) Measuring the degree of spatial correlation between histological features in thin sections of brain tissue. Neuropathology 23:245–253PubMedCrossRef

39.

Armstrong RA (1993) Is the clustering of neurofibrillary tangles in Alzheimer’s disease related to the cells of origin of specific cortico-cortical projections? Neurosci Lett 160:57–60PubMedCrossRef

40.

Armstrong RA, Cairns NJ, Lantos PL (1998) Clustering of Pick bodies in Pick’s disease. Neurosci Lett 242:81–84PubMedCrossRef

41.

Armstrong RA, Cairns NJ, Lantos PL (1999) Clustering of cerebral cortical lesions in patients with corticobasal degeneration. Neurosci Lett 268:5–8PubMedCrossRef

42.

Armstrong RA, Lantos PL, Cairns NJ (2007) Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases. J Neural Transm 114:1569–1577PubMedCrossRef

43.

Mountcastle VB (1979) An organizing principle for cerebral function: the unit module and the distributed system. In: Schmitt FO and Worden FG (eds) The Neurosciences. 4th Study Program, pp 21–42

44.

Brodal A (1981) Neurological Anatomy in relation to Clinical Medicine, 3rd edn. Oxford University Press, New York

45.

Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317–325PubMedCrossRef

46.

Steiner JA, Angot E, Brunden P (2011) A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ 18:1425–1433PubMedCrossRef

Title: Spatial patterns of the tau pathology in progressive supranuclear palsy
Authors: Richard A. Armstrong
Nigel J. Cairns
Publication date: 01-03-2013
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 3/2013
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-012-1006-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Spatial patterns of the tau pathology in progressive supranuclear palsy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2013

Neonatal hypoxic insult-mediated cholinergic disturbances in the brain stem: effect of glucose, oxygen and epinephrine resuscitation

CCSVI and MS: no meaning, no fact

Highlights of the Issue 3, 2013

Inositol-requiring protein 1α signaling pathway is activated in the temporal cortex of patients with mesial temporal lobe epilepsy

Practice of yoga may cause damage of both sciatic nerves: a case report

A chronic case of adult-onset Sandifer syndrome